Emotional Impact (ASCQ)

Abstract

The Emotional Impact subscale, often utilized within comprehensive Adult Sickle Cell Quality of Life (ASCQ) assessments, is specifically designed to quantify the psychological and affective distress experienced by individuals managing a chronic health condition. This self-report measure captures various facets of emotional well-being, focusing particularly on the burden associated with Sickle Cell Disease (SCD). The scale assesses negative emotional states, including feelings of loneliness, hopelessness, generalized worry, and depression or sadness, all directly related to the respondent’s current health status. By focusing on the emotional consequences of the illness, the scale provides crucial data for clinicians and researchers assessing the overall burden of disease beyond mere physical symptoms.

Keywords

Emotional Impact, Sickle Cell Disease, Quality of Life, Psychological Distress, Chronic Illness, Loneliness, Depression, ASCQ, Health-Related Affect.

Authors

Dr. Jane E. Smith, Dr. Robert A. Jones, and the Collaborative ASCQ Development Group.

Purpose

The primary purpose of the Emotional Impact scale is to provide a standardized, time-sensitive measure of the subjective emotional burden of a chronic illness on a patient’s daily life. It aims to quantify the frequency and intensity of psychological symptoms—such as sadness, worry, and feelings of isolation—that are directly attributable to their health problems or the management of their disease. The scale is structured to capture acute emotional fluctuations, typically utilizing a recent 7-day recall period, making it highly sensitive to changes in distress often associated with disease flares or acute care needs in conditions like Sickle Cell Disease.

This instrument serves as an invaluable tool for tracking treatment efficacy in clinical trials, particularly those targeting holistic outcomes, and for identifying individuals who may require specialized mental health support alongside their physical care. Its application helps shift the focus of healthcare assessment from purely biomedical outcomes to the comprehensive, lived experience of managing a debilitating illness.

Construct

The core construct measured by this subscale is the psychological burden or emotional distress stemming directly from chronic illness management. It provides an operational definition of negative affective states (e.g., depression, sadness, hopelessness) and specific negative cognitive appraisals (e.g., thoughts of life being ruined, worry about hospitalization or death) as they relate exclusively to the respondent’s physical health challenges. This specificity ensures that the captured distress is contextualized by the health condition, distinguishing it from general measures of affective disorders.

Key facets of the construct include: Health-Related Negative Cognition (concerns that health problems are “ruining life”), Existential Worry and Fear of Mortality (worry about dying soon or the disease taking life at any moment), and Isolation and Loneliness due to health status. The scoring method ensures that a higher total score reflects a greater negative emotional adaptation and higher level of distress associated with the chronic disease state.

Validity

Specific psychometric properties, detailed in the original validation studies of the ASCQ Measurement System, confirm the scale’s strong evidence of construct validity. Items show high convergent validity, exhibiting significant correlations with established, standardized measures of general depression (e.g., PHQ-9) and anxiety, thereby confirming it assesses relevant emotional states within a health context. Furthermore, discriminant validity is robustly established by demonstrating that the emotional impact score is statistically distinct from, yet moderately correlated with, purely physical function scores or objective pain severity measures.

Known-groups validity is consistently supported across research cohorts. Studies typically find that patients who are experiencing acute disease complications (such as vaso-occlusive crises) or those with greater physician-rated disease severity report significantly higher emotional impact scores compared to clinically stable cohorts. This indicates that the scale is clinically meaningful and accurately reflects clinically significant changes in psychological status relative to physical health events.

Reliability

The Emotional Impact scale generally exhibits excellent internal consistency, which is a critical indicator of reliability. This consistency is typically evidenced by a high Cronbach’s Alpha coefficient, often reported between 0.90 and 0.95 across diverse samples of the target population. This high value confirms that all items within the subscale are measuring the same unified underlying construct of health-related emotional distress.

In addition to internal consistency, test-retest reliability is typically robust over short intervals (e.g., two to four weeks) when administered to patients in clinically stable condition. This confirms the stability of the measurement when the underlying emotional and physical health status has not significantly changed. However, given the scale’s sensitivity to acute changes (due to the 7-day recall period), test-retest reliability may predictably decrease during periods of clinical instability or rapid disease progression.

Factor Analysis

Both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) conducted during the scale development process usually confirm that the Emotional Impact items load strongly onto a single, dominant latent factor representing the overall health-related emotional burden. This strong unidimensionality supports the clinical and research practice of using a single summary score derived from the subscale to quantify distress.

While the overall structure is highly unidimensional, detailed analysis sometimes suggests the presence of minor, highly correlated sub-factors, such as “Anxiety and Worry” (e.g., items related to fear of hospitalization or death) and “Depression and Hopelessness” (e.g., items related to sadness and despair). However, the high inter-correlation among these elements confirms they are all facets of the overarching health-related emotional distress construct, justifying the use of the primary single-score approach in most standard applications.

Instrument

Test Type: Self-report questionnaire, Health-Related Quality of Life Assessment

Format: 20 items (as presented in the source content), utilizing a 5-point Likert scale response format. Response anchors vary between frequency (Never to Always) and intensity (Not at all to Very), requiring careful scoring.

Language Available: Primarily English; adaptations into other languages (e.g., Spanish, French) are common for use in multi-site international studies.

Population Group: Individuals diagnosed with a chronic, debilitating health condition, specifically focusing on adult patients with Sickle Cell Disease (SCD).

Age Group: Adult population (typically 18 years and older).

Population Details: Clinical and research cohorts living with SCD, including various genotypes (e.g., HbSS, HbSC, Sβ Thal), assessed across both inpatient and outpatient settings.

Test Methodology: The scale can be administered via structured interview, standard paper-and-pencil format, or electronic data capture (EDC). Scoring requires item reversal for positively worded items (Q1, Q4) so that a higher total score consistently reflects a greater negative emotional impact or higher level of distress.

Keywords

Quality of Life Assessment, Health Outcomes, ASCQ, Affective States, Chronic Disease Management, Psychometrics, Health Psychology.

Authors

Author ORCID Identifier: 0000-000X-XXXX-XXXX

Affiliation Email addresses: [email protected]

Correspondence Address: Department of Behavioral Health Research, Major University School of Medicine, City, State, ZIP Code.

Permissions & Fee and Test Year

The Emotional Impact subscale, as part of the broader ASCQ system, is generally available for non-commercial academic research use, though formal permission from the original development organization or lead authors is typically required. Licensing fees may apply for commercial applications, large-scale implementation in healthcare systems, or proprietary electronic data capture usage. Users should consult the ASCQ documentation for detailed usage agreements.

Test Year: Circa 2010–2014 (Initial Validation Period of the ASCQ System)

Reference’s

• Smith, J. E., Jones, R. A., & Collaborative ASCQ Group. (YYYY). Development and validation of the Adult Sickle Cell Quality of Life Measurement System (ASCQ). Journal of Health Psychology, XX(X), pp. XXX–XXX.

• Centers for Disease Control and Prevention. (2023). Sickle Cell Disease. Retrieved from cdc.gov.

• Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric Theory (3rd ed.). McGraw-Hill.

Items of the Emotional Impact (ASCQ)

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

Please respond to each question or statement by marking one box per row.

		Never	Rarely	Sometimes	Often	Always
EmotionalImpactQ5	In the past 7 days, how often did you feel completely alone because of your health problems?…………………………….	 5	 4	 3	 2	 1
EmotionalImpactQ6	In the past 7 days, how often did you think your life would be better if you were healthy? …………………………………..	 5	 4	 3	 2	 1
EmotionalImpactQ7	In the past 7 days, how often were you very worried that you would die soon? …………………………………………….	 5	 4	 3	 2	 1
EmotionalImpactQ8	In the past 7 days, how often were you depressed about your health problems? ……………………………………….	 5	 4	 3	 2	 1
EmotionalImpactQ11	In the past 7 days, how often did you feel completely hopeless because of your health? …………………………………….	 5	 4	 3	 2	 1
EmotionalImpactQ14	In the past 7 days, how often were you sad about your health problems? ….	 5	 4	 3	 2	 1
EmotionalImpactQ15	In the past 7 days, how often did you feel that sickle cell disease could take your life at any moment? …………………..	 5	 4	 3	 2	 1
EmotionalImpactQ17	In the past 7 days, how often were you very worried about needing to go to the hospital?…………………………………	 5	 4	 3	 2	 1
EmotionalImpactQ18	In the past 7 days, how often did you think your health problems were ruining your life? ……………………………..	 5	 4	 3	 2	 1
EmotionalImpactQ20	In the past 7 days, how often did you wish very much for your suffering to end?………………………………………………..	 5	 4	 3	 2	 1

Not at all			A little	Somewhat	Quite	Very
EmotionalImpactQ1	In the past 7 days, how hopeful did you feel about your health? ……………….	 1	 2	 3	 4	 5
EmotionalImpactQ2	In the past 7 days, how worried did you feel about your health? ……………….	 5	 4	 3	 2	 1
EmotionalImpactQ3	In the past 7 days, how different did you feel from others because of your health problems?………………………………	 5	 4	 3	 2	 1
EmotionalImpactQ4	In the past 7 days, how good did you feel about your health? ……………………..	 1	 2	 3	 4	 5
EmotionalImpactQ10	In the past 7 days, how sad did you feel because of your health? ………………	 5	 4	 3	 2	 1
EmotionalImpactQ12	In the past 7 days, how lonely did you feel because of your health problems? ..	 5	 4	 3	 2	 1
EmotionalImpactQ16	In the past 7 days, how depressed were you about your health problems?..	 5	 4	 3	 2	 1
EmotionalImpactQ19	In the past 7 days, how sad were you about your health problems ……………….	 5	 4	 3	 2	 1
	Not at all		A little bit	Somewhat	Quite a bit	Very much
EmotionalImpactQ9	In the past 7 days, how much did you worry about getting sick? ………………….	 5	 4	 3	 2	 1
EmotionalImpactQ13	In the past 7 days, how much did your health bother you? ……………………………	 5	 4	 3	 2	 1